CVE detail

CVE-2023-40153 — CVE-2023-40153

Published 2023-10-19 · Modified 2026-06-17 · Vendor dexma · Product dexgate · Source nvd

MEDIUM

severity

CVSS-derived band

5.4

CVSS v3

0–10 scale

0.0030

EPSS probability

exploitation probability, 30d

22.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.